1. Recombinant human erythropoietin does not increase clotting in vascular accesses;Besarab;ASAIO Trans,1990
2. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis;Winearls;Lancet,1986
3. Treatment of the anemia of hemodialysis patients with recombinant human erythropoietin;Schaefer;Int J Artif Organs,1988
4. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis;Casati;Br Med J,1987
5. Recombinant human erythropoietin therapy in haemodialysis patients-Dose determination and clinical experience;Bommer;Nephrol Dial Transplant,1987